Hangzhou Tomson Biopharma Co., Ltd.

About Hangzhou Tomson Biopharma Co., Ltd.

HANGZHOU TOMSON BIOPHARMA CO., LTD.,a Chinese-based & worldwide operating company, which specializes in marketing, manufacture and R&D of Intermediate, API and Formulation, has professional and extensive networks in Europe, North & South America and Asia.

Our manufacturing and R&D base is located in Zhejiang, owing GMP approved synthesis & fermentation workshops and pilot workshops, which is ideal for cooperative development, technology transfer and industrialization.

Standing out for our advantaged and long-term presence in China, we are keeping well contact with hundreds of Chinese pharmaceutical companies, representative for many API & Formulation manufacturers and exclusively marketing their products.

We sincerely look forward to being your reliable and long-lasting partner, offering you our unique service as well as high-quality products.

Certifications
  • CN
  • 2018
    On CPHI since
  • 3
    Certificates
  • 25 - 49
    Employees
Company types
Biopharmaceutical company
Manufacturer/Innovator
Pharmaceutical company
Primary activities
API Producer
Biopharmaceutical
Generic APIs producer
Pharmaceutical Company (generic finished products)
Supply Chain
Contact info
  • Building 8, Rising Center, No.369, Qingchuan Street,, Xihu District,, 310030, Hangzhou,, Zhejiang,, China
Meet us at

CPHI North America 2024

Pennsylvania Convention Center, Philadelphia
07 May 2024 - 09 May 2024

CPHI & PMEC China 2024

Shanghai New International Expo Center
19 - 21 June 2024

CPHI Korea 2024

COEX, Seoul, Korea
27 - 29 August 2024

CPHI Milan 2024

Fiera Milano, Italy
08 Oct 2024 - 10 Oct 2024

Products from Hangzhou Tomson Biopharma Co., Ltd. (15)

  • Apalutamide

    Product Apalutamide

    Prostatic Neoplasms
  • Aprotinin

    Product Aprotinin

    EU approved.
  • Atogepant

    Product Atogepant

    Atogepant, is a medication used to prevent migraines. It is a gepant, an orally active calcitonin gene-related peptide receptor antagonist. 
  • Caspofungin Acetate

    Product Caspofungin Acetate

    A cyclic lipopeptide echinocandin and beta-(1,3)-D-glucan synthase inhibitor that is used to treat internal or systemic MYCOSES.
  • Dydrogesterone

    Product Dydrogesterone

    Generic APIs. 
  • Everolimus
  • Liraglutide

    Product Liraglutide

    First Generic player in China. 
  • Micafungin

    Product Micafungin

    Micafungin is a cyclic hexapeptide echinocandin antibiotic which exerts its effect by inhibiting the synthesis of 1,3-beta-D-glucan, an integral component of the fungal cell wall. It is used as the sodium salt for the treatment of invasive candidiasis, and of aspergillosis in patients who are int...
  • Posaconazole
  • Rimegepant

    Product Rimegepant

    Generic APIs. 
  • Semaglutide

    Product Semaglutide

    FDA EIR letter available for Manufacturing site

Hangzhou Tomson Biopharma Co., Ltd. Resources (2)